DMAC - DiaMedica Therapeutics Inc.'s (DMAC) CEO Rick Pauls on Q1 2020 Results - Earnings Call Transcript
DiaMedica Therapeutics Inc. (DMAC)
Q1 2020 Results Earnings Conference Call
May 14, 2020, 08:00 AM ET
Company Participants
Rick Pauls - President, Chief Executive Officer
Scott Kellen - Chief Financial Officer
Harry Alcorn - Chief Medical Officer
Conference Call Participants
Alexander Nowak - Craig-Hallum Capital Group
Thomas Flaten - Lake Street Capital
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Conference Call to discuss the topline results from DiaMedica's ReMEDy Phase 2 clinical study and Acute Ischemic Stroke and First Quarter Results. An audio recording of the webcast and a